G2B awarded with Biotech New Frontiers 2022

Gate2Brain awarded with Biotech New Frontiers 2022

Gate2Brain attended the 5th Congress of Medical Biotechnology / 2nd Congress of Iberian Medical Biotechnology held last week at the Escola Superior de Saúde do Politécnico do Porto, where our CEO, Meritxell Teixió, gave a plenary lecture.

The main goal of this meeting was to create a scientific framework in the field of Medicinal Biotechnology and related fields, to promote the exchange of ideas and experiences, collaboration and mobility among researchers, particularly from Portugal and Spain and contribute to a better and broader international agenda for Medicinal Biotechnology.

Gate2Brain’s unexpected joy reached its peak when we found out that we had been granted the Biotech New Frontiers Award 2022.

This award is for all those who have contributed to making Gate2Brain a reality, thus bringing medicines beyond barriers. Thank you very much.